Literature DB >> 20485194

Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients.

Takeshi Horio1, Yoshio Iwashima, Kei Kamide, Takeshi Tokudome, Fumiki Yoshihara, Satoko Nakamura, Yuhei Kawano.   

Abstract

OBJECTIVE: Chronic kidney disease (CKD) has recently been recognized to be a powerful predictor of cardiovascular morbidity and mortality. Atrial fibrillation (AF), which is a common arrhythmia in hypertensives, is associated with increased risks of cardiovascular events and death. However, the association between CKD and the onset of AF has not been fully elucidated. The present study assessed the hypothesis that CKD may influence the onset of AF in hypertensives.
METHODS: A total of 1118 hypertensive patients (mean age, 63 years) without previous paroxysmal AF, heart failure, myocardial infarction, or valvular disease were enrolled. CKD was defined as decreased glomerular filtration rate (<60 ml/min per 1.73 m) and/or the presence of proteinuria (>or=1+).
RESULTS: During follow-up periods (mean, 4.5 years), 57 cases of new-onset AF were found (1.1% per year). Kaplan-Meier curves revealed that the cumulative AF event-free rate was decreased in the CKD group (log-rank test P < 0.001). By univariate Cox regression analysis, age, smoking, left atrial dimension, left ventricular mass index, and the presence of CKD were significantly associated with the occurrence of AF. Among these possible predictors, CKD (hazard ratio 2.18, P = 0.009) was an independent determinant for the onset of AF in multivariate analysis. Advanced stages of CKD (stages 4 and 5) were strongly related to the increased occurrence of AF.
CONCLUSION: The present study demonstrated that the complication of CKD, especially progressed renal dysfunction, was a powerful predictor of new-onset AF in hypertensive patients, independently of left ventricular hypertrophy and left atrial dilatation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485194     DOI: 10.1097/HJH.0b013e32833a7dfe

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  39 in total

1.  The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.

Authors:  Hideki Koike; Toshisuke Morita; Junko Tatebe; Ippei Watanabe; Makiko Koike; Shintaro Yao; Masaya Shinohara; Hitomi Yuzawa; Takeya Suzuki; Tadashi Fujino; Takanori Ikeda
Journal:  Heart Vessels       Date:  2018-11-08       Impact factor: 2.037

2.  Incidence and Implications of Atrial Fibrillation/Flutter in Hypertension: Insights From the SPRINT Trial.

Authors:  Vibhu Parcha; Nirav Patel; Rajat Kalra; Joonseok Kim; Orlando M Gutiérrez; Garima Arora; Pankaj Arora
Journal:  Hypertension       Date:  2020-05-04       Impact factor: 10.190

Review 3.  Role of direct oral anticoagulants in patients with kidney disease.

Authors:  Vimal K Derebail; Michelle N Rheault; Bryce A Kerlin
Journal:  Kidney Int       Date:  2019-12-24       Impact factor: 10.612

4.  Chronic kidney disease is associated with the incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Alvaro Alonso; Faye L Lopez; Kunihiro Matsushita; Laura R Loehr; Sunil K Agarwal; Lin Y Chen; Elsayed Z Soliman; Brad C Astor; Josef Coresh
Journal:  Circulation       Date:  2011-06-06       Impact factor: 29.690

5.  Relation of renal function to risk for incident atrial fibrillation in women.

Authors:  Roopinder K Sandhu; Tobias Kurth; David Conen; Nancy R Cook; Paul M Ridker; Christine M Albert
Journal:  Am J Cardiol       Date:  2011-11-17       Impact factor: 2.778

6.  Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.

Authors:  Nisha Bansal; Dongjie Fan; Chi-yuan Hsu; Juan D Ordonez; Greg M Marcus; Alan S Go
Journal:  Circulation       Date:  2012-12-28       Impact factor: 29.690

Review 7.  Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.

Authors:  Vivencio Barrios; Carlos Escobar
Journal:  J Atr Fibrillation       Date:  2011-12-20

Review 8.  The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

Authors:  David D McManus; Jane S Saczynski; Jeanine A Ward; Khushleen Jaggi; Peter Bourrell; Chad Darling; Robert J Goldberg
Journal:  J Atr Fibrillation       Date:  2012-06-15

9.  Prediction of Atrial Fibrillation by B-type Natriuretic Peptide.

Authors:  Hiroyuki Takase; Yasuaki Dohi; Hiroo Sonoda; Genjiro Kimura
Journal:  J Atr Fibrillation       Date:  2013-04-06

10.  Impact of atrial fibrillation on the risk of ischemic stroke in patients on hemodialysis: BOREAS-HD3 Study.

Authors:  Ayumu Kimura; Marenao Tanaka; Norihito Moniwa; Arata Osanami; Koki Abe; Daisuke Miyamori; Yufu Gocho; Satoru Shibata; Makoto Terasawa; Yusuke Okazaki; Tomohisa Yamashita; Masayuki Koyama; Masato Furuhashi; Hirofumi Ohnishi; Tetsuji Miura
Journal:  Clin Exp Nephrol       Date:  2020-11-18       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.